Design of novel derivatives of phosphonoformate (Foscarnet) as prodrugs and antiviral agents

Journal of Organic Chemistry

Volumn 65, Issue 4, 2000, Pages 1218-1221

  Ferguson, Colin G ^a   Gorin, Boris I ^a   Thatcher, Gregory R J ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; FOSCARNET; PRODRUG;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING SITE; CYCLIZATION; DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG HYDROLYSIS; DRUG METABOLISM; DRUG PENETRATION; DRUG STRUCTURE; SYNTHESIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; CYTOMEGALOVIRUS INFECTIONS; DRUG DESIGN; FOSCARNET; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PRODRUGS;

EID: 0034712148     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo9912909     Document Type: Article

References (16)

1. Oberg, B. Pharmac. Ther. 1989, 40, 213.
2. (a) Noren, J. O.; Helgstrand, E.; Johansson, N. G.; Misiorny, A.; Stenning, G. J. Med. Chem. 1983, 26, 264.
3. (b) Iyer, R. P.; Boal, J. H.; Phillips, L. R.; Thakker, D. R.; Egan, W. J. Pharm. Sci. 1994, 83, 1269.
4. (a) Krol, E. S.; Thatcher G. R. J. J. Chem. Soc., Perkin Trans. 2 1993, 793.
5. (b) Krol, E. S.; Davis, J. M.; Thatcher, G. R. J. J. Chem. Soc., Chem. Commun. 1991, 118.
6. (c) Mitchell, A. G.; Nichols; D. Irwin, W. J.; Freeman, S. J. Chem. Soc., Perkin Trans. 2 1992, 1145.
7. (d) Thatcher G. R. J.; Krol, E. S.; Cameron D. R. J. Chem. Soc., Perkin Trans 2 1994, 683.
8. Ferguson, C. G.; Thatcher, G. R. J. Synlett 1998, 1325.
9. Gorin, B. I.; Ferguson, C. G.; Thatcher, G. R. J. Tetrahedron Lett. 1997, 2491.
10. Thatcher, G. R. J.; Kluger, R. H. Adv. Phys. Org. Chem. 1989, 25, 99.
11. For example: Tole, P.; Lim, C. J. Am. Chem. Soc. 1994, 116, 3922.
12. 2 in air until control wells showed characteristic cytopathic effects (24-48 h). Cells were lysed with Triton X-100 and viral antigen content of the supernatants measured by ELISA. (b) The liver and portion of the small intestine were removed from male Sprague-Dawley rats, thoroughly cleaned with deionized water, and homogenized in three (liver) or two (intestine) times their weight in Tris buffer (50 mmol, pH 7.5). Portions of the homogenates (15-30 mL) were incubated at 37 °C, the reactions were initiated by the addition of test substances in buffer (1 mM final concentration), and the mixtures were shaken. Samples (0.5 mL) were removed after 0, 5, 15, 60, and 240 min, added to methanol (0.5 mL), and centrifuged. The supernatant was then analyzed for PFA by HPLC (Pettersson, K. J.; Nordgren, T.; Westerlund, D. J. Chromat. 1989, 488, 447.). Bioassays performed by Astra Arcus, Sodertalje, Sweden.
13. Ferguson, C. G.; Thatcher, G. R. J. Org. Lett. 1999, 1, 829.
14. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Gill, P. M. W.; Johnson, M. A.; Robb, M. A.; Cheeseman, J. R.; Keith, T. A.; Petersson, G. A.; Montgomery, J. A.; Raghavachari, K.; Al-Laham, M. A.; Zakrzewski, V. G.; Ortiz, J. V.; Foresman, J. B.; Cioslowski, J.; Stefanov, B. B.; Nanayakkara, A.; Challacombe, M.; Peng, C. Y.; Ayala, P. Y.; Chen, W.; Wong, M. W.; Andres, J. L.; Replogle, E. S.; Gomperts, R.; Martin, R. L.; Fox, D. J.; Binkley, J. S.; Defrees, D. J.; Baker, J.; Stewart, J. P.; Head-Gordon, M.; Gonzalez, C.; Pople, J. A. Gaussian Inc., Pittsburgh, PA, 1995.
15. Hehre, W. J.; Radom, L.; Schleyer P.v. R.; Pople, J. A. Ab Initio Molecular Orbital Theory; John Wiley & Sons: New York 1986. DeFrees, D. J.; McLean, A. D. J. Comput. Chem 1986,. 7, 321.
16. Hehre, W. J.; Radom, L.; Schleyer P.v. R.; Pople, J. A. Ab Initio Molecular Orbital Theory; John Wiley & Sons: New York 1986. DeFrees, D. J.; McLean, A. D. J. Comput. Chem 1986,. 7, 321.